Treatment with a low-dose triple-combination pill (GMRx2) reduced the risk of recurrent stroke by 39% in patients with previous brain bleeding and high blood pressure. The TRIDENT trial, published in NEJM, found that the single-pill regimen prevented one stroke for every 35 patients.
Read Full Article
#StrokePrevention #TRIDENTTrial #NEJMResearch
Read Full Article
#StrokePrevention #TRIDENTTrial #NEJMResearch
The New England Journal of Medicine
Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage | NEJM
Blood-pressure reduction is the only proven treatment to prevent stroke due to intracerebral
hemorrhage. Whether a single pill that combines three antihypertensive drugs at low
doses, in addition t...
hemorrhage. Whether a single pill that combines three antihypertensive drugs at low
doses, in addition t...